227 related articles for article (PubMed ID: 31901178)
21. The expression, function, and clinical relevance of B7 family members in cancer.
Seliger B; Quandt D
Cancer Immunol Immunother; 2012 Aug; 61(8):1327-41. PubMed ID: 22695874
[TBL] [Abstract][Full Text] [Related]
22. B7-H3 in tumors: friend or foe for tumor immunity?
Li G; Quan Y; Che F; Wang L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):245-253. PubMed ID: 29299639
[TBL] [Abstract][Full Text] [Related]
23. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
24. T cell costimulation and coinhibition: genetics and disease.
Scandiuzzi L; Ghosh K; Zang X
Discov Med; 2011 Aug; 12(63):119-28. PubMed ID: 21878189
[TBL] [Abstract][Full Text] [Related]
25. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
26. Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6.
Cao G; Wang J; Zheng X; Wei H; Tian Z; Sun R
J Biol Chem; 2015 Dec; 290(50):29964-73. PubMed ID: 26472927
[TBL] [Abstract][Full Text] [Related]
27. Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.
Eichmüller SB; Osen W; Mandelboim O; Seliger B
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383653
[TBL] [Abstract][Full Text] [Related]
28. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells.
Geldhof AB; Moser M; Lespagnard L; Thielemans K; De Baetselier P
Blood; 1998 Jan; 91(1):196-206. PubMed ID: 9414285
[TBL] [Abstract][Full Text] [Related]
30. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
31. B7-H5 blockade enhances CD8
Wang J; Wu H; Chen Y; Zhu J; Sun L; Li J; Yao Z; Chen Y; Zhang X; Xia S; Chen W; Shi T
Cell Death Discov; 2021 Sep; 7(1):248. PubMed ID: 34537815
[TBL] [Abstract][Full Text] [Related]
32. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
[TBL] [Abstract][Full Text] [Related]
33. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
34. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.
Picarda E; Ohaegbulam KC; Zang X
Clin Cancer Res; 2016 Jul; 22(14):3425-3431. PubMed ID: 27208063
[TBL] [Abstract][Full Text] [Related]
35. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
[TBL] [Abstract][Full Text] [Related]
36. CD28-B7 interactions in T-cell activation.
Allison JP
Curr Opin Immunol; 1994 Jun; 6(3):414-9. PubMed ID: 7522466
[TBL] [Abstract][Full Text] [Related]
37. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
38. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
Front Immunol; 2019; 10():306. PubMed ID: 30863408
[TBL] [Abstract][Full Text] [Related]
39. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
Schildberg FA; Klein SR; Freeman GJ; Sharpe AH
Immunity; 2016 May; 44(5):955-72. PubMed ID: 27192563
[TBL] [Abstract][Full Text] [Related]
40. CD28: A New Drug Target for Immune Disease.
Xia S; Chen Q; Niu B
Curr Drug Targets; 2020; 21(6):589-598. PubMed ID: 31729942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]